ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Intramural AIDS Vaccine Research Center In Development By NCI, NIAID Scientists

June 13, 1997

DRCCA To Get Name Change, Three Major Program Areas

August 27, 1982

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991